Regulatory & Legal

A Romanian AI firm's tech has entered the DoD's ultra-secure Iron Bank, offering advanced, air-gapped text analytics for mission-critical intelligence.

Moving beyond dashboards, IntegriChain's new conversational AI promises trusted, auditable insights to navigate biopharma's complex commercial landscape.

A UK firm's breakthrough blood test for early breast cancer detection joins a prestigious EU network, aiming to personalize treatment and redefine diagnostics.

With its AI-powered blood test nearing FDA review, DELFI Diagnostics adds a top biotech CFO to its board, signaling major commercial and IPO ambitions.

A landmark partnership aims to solve the AI power crunch by deploying massive floating data centers, turning global shipyards into server farms.

Penske Truck Leasing honored 13 top suppliers, revealing a strategic focus on quality and partnership to navigate an increasingly complex logistics industry.

A financially struggling healthcare firm makes a bold leap into neurotechnology, but can it compete with giants like Neuralink in the high-risk BCI race?

Once a promising EV startup, Bollinger Motors has collapsed. Its complete manufacturing assets and new trucks are now up for auction in a cautionary tale.

A new long-term deal for the INTERCEPT system highlights a critical shift towards proactive pathogen reduction to protect France's blood supply from global threats.

As Washington doubles down on AI, cybersecurity firm Electrosoft hires the architect of a major federal tech overhaul to scale its operations and impact.

VSCP's appointment of Kurt Hilzinger signals a strategic push to leverage deep operational expertise in the competitive healthcare private equity market.

The iconic NewYork.com domain is for sale, sparking a confidential battle among global giants for control over the city's multi-billion-dollar tourism market.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

After four failed challenges from Microsoft, a small US firm's touchscreen patent case reaches China's highest court, setting the stage for a landmark ruling.

A landmark study reveals essential phospholipids significantly reduce liver fat and fatigue in MASLD patients, offering a new tool against a silent epidemic.

The firm known for property-level climate data now lets investors connect physical risks to corporate earnings, credit, and valuations across entire portfolios.

J&T's 2025 ESG report reveals a major push into sustainable tech and a landmark labor deal, positioning the firm as a leader in responsible logistics.

As Weibo prepares its Q1 2026 results, investors are watching closely. Can its AI pivot overcome user decline, fierce competition, and new ad regulations?

In a Texas community, nine centenarians are thriving. Their secret isn't just personal habits, but a model of care that challenges how we view aging.

PMC Organometallix announces a 10-25% price hike, a move echoed by rivals, signaling how geopolitical turmoil is driving up costs for everyday goods.